Sanjay S. Shukla
2023
In 2023, Sanjay S. Shukla earned a total compensation of $1.3M as President and CEO at aTYR PHARMA, a 46% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $196,435 |
|---|---|
| Option Awards | $532,341 |
| Salary | $561,243 |
| Other | $10,506 |
| Total | $1,300,525 |
Shukla received $561.2K in salary, accounting for 43% of the total pay in 2023.
Shukla also received $196.4K in non-equity incentive plan, $532.3K in option awards and $10.5K in other compensation.
Rankings
In 2023, Sanjay S. Shukla's compensation ranked 917th out of 2,910 executives tracked by ExecPay. In other words, Shukla earned more than 68.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 917 out of 2,910 | 69th |
Division Manufacturing | 545 out of 1,602 | 66th |
Major group Chemicals And Allied Products | 370 out of 901 | 59th |
Industry group Drugs | 359 out of 864 | 58th |
Industry Biological Products, Except Diagnostic Substances | 109 out of 211 | 48th |
Source: SEC filing on April 5, 2024.
Shukla's colleagues
We found two more compensation records of executives who worked with Sanjay S. Shukla at aTYR PHARMA in 2023.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019